Short answer · Medically reviewed summary · Last updated: 2026-05-08
Maroteaux-Lamy Syndrome is officially classified in medical literature as Mucopolysaccharidosis type VI (MPS VI). It is a rare lysosomal storage disorder, and while you may encounter several historical or descriptive synonyms, "MPS VI" is the term most frequently used by clinicians and researchers today. What are the official names and synonyms for Maroteaux-Lamy Syndrome? In medical records, you will primarily see Maroteaux-Lamy Syndrome referred to as Mucopolysaccharidosis type VI (MPS VI).
Maroteaux-Lamy Syndrome synonyms
Other names for Maroteaux-Lamy Syndrome: synonyms, acronyms and related terms used by doctors and patients.
Maroteaux-Lamy Syndrome is officially classified in medical literature as Mucopolysaccharidosis type VI (MPS VI). It is a rare lysosomal storage disorder, and while you may encounter several historical or descriptive synonyms, "MPS VI" is the term most frequently used by clinicians and researchers today.
What are the official names and synonyms for Maroteaux-Lamy Syndrome?
In medical records, you will primarily see Maroteaux-Lamy Syndrome referred to as Mucopolysaccharidosis type VI (MPS VI). Because medical terminology evolves, you may encounter various names used in older literature or specific geographic regions. Understanding these synonyms is important when searching for medical records or historical research articles.
Why does Maroteaux-Lamy Syndrome have multiple names?
The condition was named after French physicians Pierre Maroteaux and Maurice Lamy, who first described the disorder in 1963. Like many rare diseases, it was initially identified by the clinicians who characterized its unique clinical features. As our understanding of the underlying biochemistry improved, the medical community shifted toward using the classification "Mucopolysaccharidosis type VI" to reflect the specific enzyme deficiency—arylsulfatase B—that causes the disease.
What are the common terms used in medical databases?
When navigating international medical classification systems, you will find Maroteaux-Lamy Syndrome listed under several designations. These include:
- Mucopolysaccharidosis type VI (MPS VI): The standard clinical designation.
- Arylsulfatase B deficiency: A description based on the underlying enzymatic cause.
- Polydystrophic dwarfism: An older, descriptive term rarely used in modern clinical settings.
- Maroteaux-Lamy disease: An alternative common nomenclature.
Which name should patients use?
While Maroteaux-Lamy Syndrome remains a widely recognized eponym, using "Mucopolysaccharidosis type VI" or "MPS VI" is often the most effective way to communicate with specialists and access current clinical research. Currently, three members of the DiseaseMaps.org community living with Maroteaux-Lamy Syndrome share their experiences using these terms to connect with global resources. Using the term MPS VI is particularly helpful when searching for clinical trials or specialized treatment protocols.
Next steps
- Confirm the specific terminology used by your metabolic specialist or geneticist during your next consultation.
- Use the term "Mucopolysaccharidosis type VI" when searching PubMed or clinicaltrials.gov for the latest research.
- Connect with the DiseaseMaps.org community to share experiences with others managing Maroteaux-Lamy Syndrome.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- Orphanet (ORPHA:587): Mucopolysaccharidosis type VI
- NIH GARD: Maroteaux-Lamy syndrome
- OMIM (Entry #253200): Mucopolysaccharidosis type VI
- National MPS Society: MPS VI Overview
